Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Shire
Shire
Takeda breaks into top 20 largest pharmas with Shire merger
Pharmaforum
Wed, 10/9/19 - 10:41 am
Takeda
Shire
M&A
Takeda eyes emerging markets asset sale to trim its debt; report
Pharmaforum
Thu, 09/26/19 - 10:45 am
Takeda
Shire
M&A
emerging markets
Europe
Takeda staffers accuse drugmaker of favoring Shire employees during merger: report
Fierce Pharma
Fri, 08/2/19 - 12:31 pm
Korea
Shire
Takeda
employees
M&A
As Takeda absorbs Shire’s R&D ops, the focus is on replacing a centralized command model with a ‘light touch’ in a restructured global organization
Endpoints
Wed, 07/24/19 - 10:39 am
Takeda
Shire
R&D
restructuring
M&A
Takeda Eyes Additional Divestitures to Pare Down Shire Deal Debt
BioSpace
Thu, 07/18/19 - 11:39 am
Takeda
Shire
M&A
In $86M IPO pitch, Mirum spells out plans to turn Shire discards into orphan liver drug successes
Endpoints
Mon, 06/24/19 - 11:14 am
Mirum
IPOs
Shire
liver disease
Servier, armed with Shire cancer drugs, builds out vision for U.S. future
Fierce Pharma
Fri, 06/7/19 - 12:47 pm
Servier
oncology
Shire
M&A
Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal
Fierce Pharma
Thu, 05/9/19 - 11:11 am
Takeda
Shire
Novartis
M&A
Xiidra
dry eye disease
Novartis Considers Offer for Takeda Eye-Disease Assets
Bloomberg
Wed, 05/8/19 - 05:25 pm
Novartis
Takeda
Shire
eye disease
M&A
Pharma AbbVie, Shire investors agree to settle lawsuit over scuttled tax-inversion deal
Fierce Pharma
Sat, 04/13/19 - 12:18 pm
AbbVie
Shire
taxes
tax inversions
M&A
14 Drugs Earn Billions for These Massachusetts Biotechs
BioSpace
Wed, 03/6/19 - 09:59 am
Massachusetts
Boston
Biogen
Tecfidera
Benepali
Shire
Takeda
Vyvanse
Vertex Pharmaceuticals
Orkambi
Kalydeco
Alexion
Soliris
Strensiq
Sanofi Genzyme
Lantus
Ironwood Pharmaceuticals
Linzess
Case Study: How Shire improved its time-to-market
Pharmaforum
Mon, 02/18/19 - 11:19 am
Shire
drug development
time-to-market
Takeda mulling sale of emerging market drugs – report
Pharmaforum
Tue, 01/22/19 - 11:39 am
Takeda
Shire
M&A
emerging markets
Takeda’s Shire takeover could herald new era of pharma M&A
Pharmaforum
Wed, 01/9/19 - 09:18 am
M&A
Takeda
Shire
taxes
Pfizer
With mega merger season in full swing, Takeda officially swallows Shire
Endpoints
Tue, 01/8/19 - 07:09 pm
Takeda
Shire
M&A
Takeda builds arsenal for immuno-oncology research, creates cell therapy group
Endpoints
Thu, 01/3/19 - 11:43 pm
Takeda
immuno-oncology
cell therapy
Shire
Shire gears up to battle Allergan's Linzess with new constipation drug Motegrity
Fierce Pharma
Wed, 12/19/18 - 12:25 am
Takeda
Shire
Allergan
chronic idiopathic constipation
Motegrity
A last-ditch effort to derail Takeda’s $62B Shire buyout goes down in flames
Endpoints
Wed, 12/5/18 - 09:46 am
Takeda
Shire
M&A
Takeda Acquisition Of Shire May Bode Well For R&D Staff
Forbes
Mon, 12/3/18 - 10:05 am
Shire
Takeda
R&D
M&A
Takeda ready to dismiss assets for a total $10bn
GoinPharma
Sun, 12/2/18 - 12:35 pm
Takeda
Shire
M&A
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »